Journal of Biosciences

, Volume 30, Issue 5, pp 567–571 | Cite as

Whither genome research: Of man, mosquito and malaria

  • Utpal Tatu
  • Samta Jain
  • P. Padma Priya


Malaria Curcumin Gossypol Plasmodium Falciparum Artemisinin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham E G, Pinto S B, Ghosh A, Vanlandingham D L, Budd A, Higgs S, Kafatos F C, Jacobs-Lorena M and Michel K 2005 An immune-responsive serpin, SRPN6, mediates mosquito defense against malaria parasites;Proc. Natl. Acad. Sci. USA 102 16327–16322PubMedCrossRefGoogle Scholar
  2. Banumathy G, Singh V, Pavithra S R and Tatu U 2003 Heat shock protein 90 function is essential forPlasmodiumfalciparum growth in human erythrocytes;J. Biol. Chem. 16 278 18336–18345CrossRefGoogle Scholar
  3. De D, Krogstad F M, Byers L D and Krogstad D J 1998 Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines;Med. Chem. 41 4918–4926CrossRefGoogle Scholar
  4. Eaazhisai K, Jayalakshmi R, Gayathri P, Anand R P, Sumathy K, Balaram H and Murthy M R N 2004 Crystal Structure of Fully Ligated Adenylosuccinate Synthetase fromPlasmodium falciparum;J. Mol. Biol. 335 1251–1264PubMedCrossRefGoogle Scholar
  5. Francis S E, Gluzman I Y, Oksman A, Knickerbocker A, Mueller R, Bryant M L, Sherman D R, Russell D G and Goldberg D E 1994 Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase;EMBO J. 13 306–317PubMedGoogle Scholar
  6. Gero A M, Dunn, Brown C G, Pulenthiran M, Gorovits M, Bakos L and Weis A L 2003 New malaria chemotherapy developed by utilization of a unique parasite transport system;Curr. Pharm. Des. 9 867–877PubMedCrossRefGoogle Scholar
  7. Nzila A M, Nduati E, Mberu E K, Hopkins Sibley C, Monks S A, Winstanley P A and Watkins W M 2000 Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on KenyanPlasmodium falciparum;J. Infect. Dis. 181 2023–2028PubMedCrossRefGoogle Scholar
  8. Pavithra S R, Banumathy G, Joy O, Singh V and Tatu U 2004 Recurrent fever promotesPlasmodium falciparum development in human erythrocytes;J. Biol. Chem. 279 46692–46699PubMedCrossRefGoogle Scholar
  9. Rathod P K, Leffers N P and Young R D 1992 Molecular targets of 5-fluoroorotate in the human malaria parasite,Plasmodium falciparum;Antimicrob. Agents Chemother. 36 704–711PubMedGoogle Scholar
  10. Reddy R C, Vatsala P G, Keshamouni V G, Padmanaban G and Rangarajan P N 2005 Curcumin for malaria therapy;Biochem. Biophys. Res. Commun. 326 472–474PubMedCrossRefGoogle Scholar
  11. Rosenthal P J 2001Protease inhibitors. Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery (Totawa, NJ Humana Press) pp 325–345Google Scholar
  12. Surolia N and Surolia A 2001 Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase ofPlasmodium falciparum;Nat. Med. 7 167–173PubMedCrossRefGoogle Scholar
  13. Varadharajan S, Dhanasekaran S, Rangarajan P N and Padmanaban G 2002 Involvement of d-aminolevulinate synthase in de novo heme synthesis byPlasmodium falciparum;Biochem. J. 367 321–327PubMedCrossRefGoogle Scholar
  14. Waller R F, Keeling P J, Donald R G, Striepen B, Handman E, Lang-Unnasch, Cowman A F, Besra G S, Roos D and McFadden G I 1998 Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum;Proc. Natl. Acad. Sci. USA 95 12352–12357PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2005

Authors and Affiliations

  • Utpal Tatu
    • 1
  • Samta Jain
    • 1
  • P. Padma Priya
    • 1
  1. 1.Department of BiochemistryIndian Institute of ScienceBangaloreIndia

Personalised recommendations